GSM gold starGSM Global
中文版 · Chinese

FDA Issues Proposed Rule to Allow NAC in Dietary Supplements, Opens 60-Day Comment Period

Monday, November 16, 2026 · Federal · GSM News

The U.S. Food and Drug Administration (FDA) on November 16 issued a proposed rule that, if finalized, would reverse the exclusion of N-acetyl-L-cysteine (NAC) from the definition of "dietary supplement." Under the proposal, NAC-containing products could be lawfully marketed as dietary supplements, provided they are not otherwise in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The proposed rule is open for public comment for 60 days through the Federal Register.

The FDA noted that in a March 2022 response to two citizen petitions, it had concluded that NAC-containing products cannot be dietary supplements. The proposed rule would establish a new regulation, titled "Dietary Ingredients Not Excluded from the Dietary Supplement Definition," to provide for the lawful use of certain ingredients that would otherwise be excluded from the definition. The agency said this is its first use of the rulemaking authority described in the exclusion provision of the dietary supplement definition, and NAC would be the first ingredient listed under the new regulation.

The FDA said it undertook a comprehensive review and did not identify any safety concerns with the use of NAC in or as a dietary supplement. NAC-containing products represented as dietary supplements have been sold in the United States for more than 30 years, the agency said, and consumers continue to seek access to them. In August 2022, the FDA issued final guidance stating its intent to exercise temporary enforcement discretion for certain NAC products labeled as dietary supplements, and the agency said that policy will continue while the rulemaking process proceeds.

The FDA said the action, if finalized, would be a deregulatory action under President Trump's Executive Order 14192, "Unleashing Prosperity Through Deregulation." Details on how to submit a comment are in the Federal Register notice.

(Source: U.S. Food and Drug Administration)

Source: U.S. Food and Drug Administration

Published by GSM · USA (original Chinese edition)

Photo: 图:美国食品药品监管局总部大楼。美国食品药品监管局官方照片,公共领域。 / Photo: Headquarters of the U.S. Food and Drug Administration. U.S. Food and Drug Administration photo, public domain.

Latest in Federal